Streptococcus mutans can modulate biofilm formation and attenuate the virulence of Candida Albicans

PLoS ONE

Volumn 11, Issue 3, 2016, Pages

  Barbosa, Júnia Oliveira ^a   Rossoni, Rodnei Dennis ^a   Vilela, Simone Furgeri Godinho ^a   De Alvarenga, Janaína Araújo ^a   Velloso, Marisol Dos Santos ^a   De Azevedo Prata, Márcia Cristina ^b   Jorge, Antonio Olavo Cardoso ^a   Junqueira, Juliana Campos ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b EMBRAPA CERRADOS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIUM CULTURE; BIOFILM; CANDIDA ALBICANS; CANDIDIASIS; CONTROLLED STUDY; FUNGAL VIRULENCE; FUNGUS HYPHAE; GALLERIA MELLONELLA; HEMOLYMPH; IN VITRO STUDY; IN VIVO STUDY; LARVA; LIMIT OF QUANTITATION; NONHUMAN; STREPTOCOCCUS MUTANS; ANIMAL; DISEASE MODEL; GROWTH, DEVELOPMENT AND AGING; HUMAN; LEPIDOPTERA; MICROBIOLOGY; ORGANISMAL INTERACTION; PATHOGENICITY; PHYSIOLOGY;

ANIMALS; BIOFILMS; CANDIDA ALBICANS; CANDIDIASIS; DISEASE MODELS, ANIMAL; HUMANS; LARVA; LEPIDOPTERA; MICROBIAL INTERACTIONS; STREPTOCOCCUS MUTANS;

EID: 84961116889     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0150457     Document Type: Article

References (30)

1. Jarosz LM, Deng DM, van der Mei HC, Crielard W, Krom BP. Streptococcus mutans competence-stimulating peptide inhibits Candida albicans hypha formation. Eukaryot Cell. 2009; 8(11):1658-64. doi: 10.1128/EC.00070-09
2. Zijngue V, van Leeuwen MB, Degener JE, Abbas F, Thurnheer T, Gmör R, et al. Oral biofilm architecture on natural teeth. Plos One. 2010; 5(2):e9321. doi: 10.1371/journal.pone.0009321
3. Thein ZN, Seneviratne CJ, Samaranayake YH, Samaranayake LP. Community lifestyle of Candida in mixed biofilms: A mini review. Mycoses. 2009; 52(6):467-75. doi: 10.1111/j.1439-0507.2009.01719.x
4. Peleg AY, Hogan DA, Mylonakis E. Medically important bacterial-fungal interactions. Nat Rev Microbiol. 2010; 8(5)340-9. doi: 10.1038/nrmicro2313
5. Pereira-Cenci T, Deng DM, Kraneveld EA, Manders EM, Del Bel Cury AA, Ten Cate JM, et al. The effect of Streptococcus mutans and Candida glabrata on Candida albicans biofilms formed on different surfaces. Arch Oral Biol. 2008; 53(8):755-64. doi: 10.1016/j.archoralbio.2008.02.015
6. Joyner PM, Liu J, Zhang Z, Merritt J, Qi F, Cichewicz RH. Mutanobactin A from the human oral pathogen Streptococcus mutans is a cross-kingdom regulator of the yeast-mycelium transition. Org Biomol Chem. 2010; 8(24):5486-9. doi: 10.1039/c0ob00579g
7. Fuchs BB, Eby J, Nobile CJ, El Khoury JB, Mitchell AP, Mylonakis E. Role of filamentation in Galleria mellonella killing by Candida albicans. Microbes Infect. 2010; 12(6):488-96. doi: 10.1016/j.micinf.2010.03.001
8. Junqueira JC, Fuchs BB, Muhammed M, Coleman JJ, Suleiman JMAH, Vilela SFG, et al. Oral Candida albicans isolates from HIV-positive individuals have similar in vitro biofilm-forming ability and pathogenicity as invasive Candida isolates. BMC Microbiology. 2011; 11:247. doi: 10.1186/1471-2180-11-247
9. Fuchs BB, Mylonakis E. Using non-mammalian hosts to study fungal virulence and host defense. Curr Opin Microbiol. 2006; 9(4):346-51.
10. Pukkila-Worley R, Peleg AY, Tampakakis E, Mylonakis E. Candida albicans hyphal formation and virulence assessed using a Caenorhabditis elegans infection model. Eukaryot Cell. 2009; 8(11):1750-8. doi: 10.1128/EC.00163-09
11. Rowan R, Moran C, McCann M, Kavanagh K. Use of Galleria mellonella larvae to evaluate the in vivo anti-fungal activity of [Ag2(mal)(phen)3]. Biometals. 2009; 22(3):461-7. doi: 10.1007/s10534-008-9182-3
12. Mylonakis E, Aballay A. Worms and flies as genetically tractable animal models to study host-pathogen interactions. Infect Immun. 2005; 73(7):3833-41.
13. Chamilos G, Lionakis MS, Lewis RE, Kontoyiannis DP. Role of mini-host models in the study of medically important fungi. Lancet Infect Dis. 2007; 7(1):42-55.
14. Fuchs BB, Mylonakis E. Using non-mammalian hosts to study fungal virulence and host defense. Curr Opinion Microbiol. 2006; 9(4):346-51.
15. Mylonakis E. Galleria mellonella and the study of fungal pathogenesis: making the case for another genetically tractable model host. Mycopathologia. 2008; 165(1):1-3.
16. Coleman JJ, Okoli I, Tegos GP, Holson EB, Wagner FF, Hamblin MR, et al. Characterization of plantderived saponin natural products against Candida albicans. ACS Chem Biol. 2010; 5(3):321-32. doi: 10.1021/cb900243b
17. Thein ZN, Samaranayake YH, Samaranayake LP. Effect of oral bacteria on growth and survival of Candida albicans biofilms. Arch Oral Biol. 2006; 51(8):672-80.
18. Peeters E, Nelis HJ, Coenye T. Comparison of multiple methods for quantification of microbial biofilms grown in microtiter plates. J Microbiol Methods. 2008; 72(2):157-65.
19. Vilela SF, Barbosa JO, Rossoni RD, Santos JD, Prata MC, Anbinder AL et al. Lactobacillus acidophilus ATCC 4356 inhibits biofilm formation by C. albicans and attenuates the experimental candidiasis in Galleria mellonella. Virulence. 2015; 6(1):29-39. doi: 10.4161/21505594.2014.981486
20. Mylonakis E, Moreno R, El Khoury JB, Idnurm A, Heitman J, Calderwood SB, et al. Galleria mellonella as a model system to study Cryptococcus neoformans pathogenesis. Infect Immun. 2005; 73(7):3842-50.
21. Uppuluri P, Pierce CG, López-Ribot JL. Candida albicans biofilm formation and its clinical consequences. Future Microbiol. 2009; 4(10):1235-7. doi: 10.2217/fmb.09.85
22. Ribeiro DG, Pavarina AC, Dovigo LN, Machado AL, Giampaolo ET, Vergani CE. Prevalence of Candida spp. associated with bacteria species on complete dentures. Gerodontology 2012; 29(3):203-8. doi: 10.1111/j.1741-2358.2011.00578.x
23. Sztajer H, Szafranski SP, Tomasch J, Reck Michael, Nimtz M, Rohde M, et al. Cross-feeding and interkingdom communication in dual-species biofilms of Streptococcus mutans and Candida albicans. ISME J. 2014; 8(11):2256-71. doi: 10.1038/ismej.2014.73
24. Metwalli KH, Khan SA, Krom BP, Jabra-Rizk MA. Streptococcus mutans, Candida albicans, and the human mouth: A sticky situation. Plos Pathog. 2013; 9(10):e1003616. doi: 10.1371/journal.ppat. 1003616
25. Falsetta ML, Klein MI, Colonne PM, Scott-Anne K, Gregoire S, Pai CH, et al. Symbiotic relationship between Streptococcus mutans and Candida albicans synergizes virulence of plaque biofilms in vivo. Infect Immun. 2014; 82(5):1968-81. doi: 10.1128/IAI.00087-14
26. Davis D. Adaptation to environmental pH in Candida albicans and its relation to pathogenesis. Curr Genet. 2003; 44(1):1-7.
27. Abranches J, Miller JH, Martinez AR, Simpson-Haidaris PJ, Burne RA, Lemos JA. The collagen-binding protein Cnm is required for Streptococcus mutans adherence to and intracellular invasion of human coronary artery endothelial cells. Infect Immun. 2011; 79(6):2277-84. doi: 10.1128/IAI.00767-10
28. Wang X, Du L, You J, King JB, Cichewicz RH. Fungal biofilm inhibitors from a human oral microbiomederived bacterium. Org Biomol Chem 2012; 10(10):2044-50. doi: 10.1039/c2ob06856g
29. Vílchez R, Lemme A, Ballhausen B, Thiel V, Schulz S, Jansen R, et al. Streptococcus mutans inhibits Candida albicans hyphal formation by the fatty acid signaling molecule trans-2-decenoic acid (SDSF). Chem Bio Chem. 2010; 11(11):1552-62. doi: 10.1002/cbic.201000086
30. Zvanych R, Lukenda N, Kim JJ, Thamarajah S, Magarvey NA. Systems biosynthesis of secondary metabolic pathways within the oral human microbiome member Streptococcus mutans. Mol Biosyst. 2015; 11(1):97-104. doi: 10.1039/c4mb00406j